Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1+17819995354 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| NAN-190 hydrobromide | C23H28BrN3O3 | 115338-32-4 | Details |
| Nav1.7-IN-3 | C17H20ClFN4O2S2 | 1788872-06-9 | Details |
| Nav1.7 inhibitor | C15H11Cl3FNO4S | 1355631-24-1 | Details |
| Naspm；1-Naphthylacetyl spermine | C22H34N4O | 122306-11-0 | Details |
| Dianemycin | C47H78O14 | 35865-33-9 | Details |
| Nateglinide D5；Senaglinide D5;A4166 D5 | C19H22D5NO3 | 1227666-13-8 | Details |
| Natalizumab | C40H55N7O11S | 189261-10-7 | Details |
| Netupitant metabolite N-desmethyl Netupitant；N-desmethyl Netupitant | C29H30F6N4O | 290296-72-9 | Details |
| Netupitant metabolite Monohydroxy Netupitant；Monohydroxy Netupitant | C30H32F6N4O2 | 910808-12-7 | Details |
| Netupitant metabolite Netupitant N-oxide；Netupitant N-oxide | C30H32F6N4O2 | 910808-11-6 | Details |
| Neurotoxin Inhibitor | C19H14N4OS | 951571-70-3 | Details |
| NF-56-EJ40 | C27H29N3O3 | 2380230-73-7 | Details |
| Nexopamil racemate | C24H40N2O3 | 116759-35-4 | Details |
| NF546 | C47H44N6Na4O17P4 | 1006028-37-0 | Details |
| Ned 19 | C30H31FN4O3 | 874374-25-1 | Details |
| Netropsin dihydrochloride | C18H27ClN10O3 | 18133-22-7 | Details |
| Ethidium bromide；EtBr;Homidium bromide;EB | C21H20BrN3 | 1239-45-8 | Details |
| NB-598 Maleate | C31H35NO5S2 | 155294-62-5 | Details |
| NEO 376 | C20H24ClN3O | 496921-73-4 | Details |
| NFAT Transcription Factor Regulator-1 | C17H10F6N4O2 | 245747-71-1 | Details |
| Nec-4 | C15H13ClFN3O | 1041644-43-2 | Details |
| Nebracetam hydrochloride | C12H17ClN2O | 1177279-49-0 | Details |
| Nifedipine-d6；Nifedipine D6;BAY-a-1040 D6 | C17H12D6N2O6 | 1188266-14-9 | Details |
| Nifursemizone | C8H10N4O4 | 5579-89-5 | Details |
| Nevanimibe hydrochloride | C27H40ClN3O | 133825-81-7 | Details |
| NIC3 | C26H36N2O4 | 494830-67-0 | Details |
| Trifluoperazine dihydrochloride | C21H26Cl2F3N3S | 440-17-5 | Details |
| Nevanimibe；ATR-101;PD-132301 | C27H39N3O | 133825-80-6 | Details |
| Nilotinib-d6；AMN107 D6;Nilotinib D6 | C28H16D6F3N7O | 1268356-17-7 | Details |
| Nicardipine-d3 hydrochloride；Nicardipine D3 hydrochloride;YC-93 D3 | C26H26D3N3O6 | 1432061-50-1 | Details |
| Niperotidine | C20H26N4O5S | 84845-75-0 | Details |
| Niraparib metabolite M1；Niraparib carboxylic acid metabolite M1;M1 metabolite of niraparib | C19H19N3O2 | 1476777-06-6 | Details |
| Nimesulide D5 | C13H7D5N2O5S | 1330180-22-7 | Details |
| NIM811；SDZ NIM811;(Melle-4)cyclosporin | C62H111N11O12 | 143205-42-9 | Details |
| Nitroxazepine | C18H19N3O4 | 47439-36-1 | Details |
| NMDA-IN-1 | C20H23ClFN3O | 700878-19-9 | Details |
| Norverapamil-d7；D591 D7;(±)-Norverapamil D7;Norverapamil D7 | C26H29D7N2O4 | 263175-44-6 | Details |
| NNC45-0781 | C27H29NO3 | 207277-66-5 | Details |
| Cefuroxime sodium | C16H15N4O8S.Na | 56238-63-2 | Details |
| Naphthoquine phosphate | C24H31ClN3O5P | 173531-58-3 | Details |
| NHE3-IN-1 | C12H10ClN3S | 632355-68-1 | Details |
| NCX899 | C23H33N3O8 | 690655-41-5 | Details |
| NB-598 hydrochloride | C27H32ClNOS2 | 136719-25-0 | Details |
| NED-3238 | C17H28BN3O4 | 2389062-09-1 | Details |
| Nepafenac-d5；AHR-9434 D5;Nepafenac D5;AL-6515 D5 | C15H14N2O2 | 1246814-53-8 | Details |
| NecroX-5 | C26H35N3O6S2 | 1383718-29-3 | Details |
| NCT-506 | C25H23FN4O3S | 2231098-99-8 | Details |
| Acetylcholine chloride | C7H16ClNO2 | 60-31-1 | Details |
| Necrostatin 2 | C13H12ClN3O2 | 852391-19-6 | Details |
| Necrostatin 2 S enantiomer | C13H12ClN3O2 | 852391-20-9 | Details |
| NCGC00247743 | C24H29N3O2 | 1435192-04-3 | Details |
| NCGC00249987 | C16H11FN4O2S | 1384864-80-5 | Details |
| NCT-505 | C27H28FN5O3S | 2231079-74-4 | Details |
| NCGC00229600 | C30H29N3O3 | 1338824-20-6 | Details |
| NCI172112；NSC268497;NSC172112 | C14H23Cl2N3O2 | 56605-16-4 | Details |
| NBTGR | C17H18N6O6S | 13153-27-0 | Details |
| Cefoperazone sodium salt | C25H28N9NaO8S2 | 62893-20-3 | Details |
| NB-360 | C21H19F4N5O2 | 1262857-73-7 | Details |
| Navitoclax-piperazine | C47H56ClF3N6O5S3 | 2143096-93-7 | Details |
| Nav1.7-IN-6 | C25H25ClF6N2O4S | 1788066-71-6 | Details |
| Trans (2,3)-Dihydrotetrabenazine；(2R,3R,11bR)-rel-Dihydrotetrabenazine;(2R,3R,11bR)-rel-DHTBZ | C19H29NO3 | 171598-74-6 | Details |
| Nav1.7-IN-2 | C22H22FN5O2 | 1332295-35-8 | Details |
| NaV1.7 inhibitor-1 | C23H30FNO4S | 1494585-79-3 | Details |
| NBDHEX | C12H15N3O4S | 787634-60-0 | Details |
| Naspm trihydrochloride | C22H35ClN4O | 1049731-36-3 | Details |
| Nav1.1 activator 1 | C24H23F3N4O | 2332897-85-3 | Details |
| Sisomicin Sulfate | C19H39N5O11S | 53179-09-2 | Details |
| Naveglitazar racemate | C25H26O6 | 916085-47-7 | Details |
| Naquotinib mesylate；ASP8273 (mesylate) | C31H46N8O6S | 1448237-05-5 | Details |
| Naratriptan D3 Hydrochloride；GR-85548A D3 | C17H25ClN3O2S | 1190021-64-7 | Details |
| Norbinaltorphimine dihydrochloride | C40H44ClN3O6 | 113158-34-2 | Details |
| NMS-P715 | C35H39F3N8O3 | 1202055-32-0 | Details |
| NMS-859 | C15H12ClN3O3S | 1449236-96-7 | Details |
| NMDI14 | C21H25N3O4S | 307519-88-6 | Details |
| NK-1 Antagonist 1；Rolapitant intermediate | C25H23F6N5O2 | 873947-10-5 | Details |
| nor-NOHA acetate；Nω-Hydroxy-nor-L-arginine acetate | C5H12N4O3 ? 2C2H4O2 | 1140844-63-8 | Details |
| Norvancomycin hydrochloride；Desmethyl-vancomycin hydrochloride | C65H74Cl3N9O24 | 213997-73-0 | Details |
| NNC 55-0396 | C30H39ClFN3O2 | 357400-13-6 | Details |
| Nitazoxanide-d4；NSC-697855 D4;Nitazoxanide D4;NTZ D4 | C12H9N3O5S | 1246819-17-9 | Details |
| Ceftriaxone sodium hydrate | C18H21N8NaO8S3 | 104376-79-6 | Details |
| NITD-349 | C17H20F2N2O | 1473450-62-2 | Details |
| Nosantine racemate；NPT-15392 racemate | C14H22N4O2 | 75166-67-5 | Details |
| Norverapamil；(±)-Norverapamil;D591 | C26H36N2O4 | 67018-85-3 | Details |
| CB-103 | C15H18N2O | 218457-67-1 | Details |
| NPB | C29H31Cl2N3O2 | 2247491-97-8 | Details |
| NRA-0160 | C24H23F2N3OS | 204718-47-8 | Details |
| NS8593 hydrochloride | C17H17N3.ClH | 875755-24-1 | Details |
| NSC 601980 (analog) | C15H14N4 | 91757-46-9 | Details |
| NSC232003 | C6H7N3O3 | 1905453-18-0 | Details |
| NSC117079 | C20H15N3O7S2 | 500363-63-3 | Details |
| NPS ALX Compound 4a | C25H25N3O2S | 299433-10-6 | Details |
| Bacitracin | C66H102N17O16S | 1405-87-4 | Details |
| NSC 146109 hydrochloride | C17H17ClN2S | 59474-01-0 | Details |
| NS-3-008 hydrochloride | C14H24ClN3 | 1172854-54-4 | Details |
| NS19504 | C10H9BrN2S | 327062-46-4 | Details |
| Nourseothricin sulfate | C44H82N18O21S | 96736-11-7 | Details |
| NOT Receptor Modulator 1；2-(3-(2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl)phenyl)propan-2-ol | C22H19ClN2O | 1015231-98-7 | Details |
| NR1H4 activator 1 | C34H53NO7S | 2242855-68-9 | Details |
| Nrf2-IN-1 | C21H22ClN3O2 | 1610022-76-8 | Details |
| NPS ALX Compound 4a dihydrochloride | C25H26ClN3O2S | 1781934-44-8 | Details |
| Product Total： Product Page： | ||||
| 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 | ||||